Elsevier selected as publisher of the Journal of Social Studies Research

December 17, 2012

Oxford, December 17, 2012 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that the International Society for the Social Studies has selected Elsevier to publish The Journal of Social Studies Research (JSSR) beginning in January 2013.

Published four times a year, The Journal of Social Studies Research is an internationally recognized peer-reviewed journal designed to foster the dissemination of ideas and research findings related to the social studies.

Associate Professor William B. Russell, Director of the International Society for the Social Studies and Editor-in-Chief of JSSR said, "We are very pleased work with Elsevier. As a leading journal in field of social studies education, collaborating with Elsevier will help ensure that JSSR continues to move forward and stay abreast on the current publishing trends and the needs of our authors and readers."

Ann Corney, Executive Publisher at Elsevier added, "We are extremely excited to working closely with the International Society for the Social Studies and the University of Central Florida on this publication. We look forward to bringing The Journal of Social Studies Research to a wider, international audience and working with the journal's editorial team to develop an enhanced publishing experience for readers, authors and reviewers."
-end-
For more information go to: http://www.journals.elsevier.com/the-journal-of-social-studies-research/.

About The International Society for the Social Studies

The International Society for the Social Studies (ISSS) is a non-profit, professional society devoted to the social studies. ISSS is an international interdisciplinary society for individuals striving to promote and enhance the importance of social studies education across the world.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact

Lyndsay Scholefield
Elsevier

Elsevier

Related Announce Articles from Brightsurf:

Female directors are quicker to recall dangerous medical products, study shows
Some 4,500 Food and Drug Administration-approved drugs and devices are pulled from shelves annually -- decisions greatly influenced by the presence of women on a firm's board, according to new research from the University of Notre Dame.

Chewing gum use in the perioperative period
Many anesthesiologists forbid patients from chewing gum in the immediate hours before surgery for fear that it would increase the risk that the patient's stomach contents might end up dumped (aspirated) into the patient's lungs, with potentially deadly consequences (aspiration pneumonitis).

NSF and Popular Science announce winners of 15th annual 'Vizzies'
'Vizzies' competition recognizes the best photographs, videos, illustrations, interactive apps, and posters and graphics produced by academic researchers, artists or hobbyists.

Four year agreement to supply Silicon Carbide micro-fiber
Haydale Graphene Industries plc the UK listed global nanomaterials group, is pleased to announce that its subsidiary, Advanced Composite Materials LLC, has entered into a four-year agreement to supply Silicon Carbide micro-fiber to a global industrial manufacturer of tooling and wear-resistant solutions.

BioCanRx, and partners, announce funding to manufacture first made-in-Canada CAR-T cells
BioCanRx, and its partners, today announced funding for 16 collaborative research projects in novel therapies to cure cancer including research aimed at developing clinical Chimeric Antigen Receptor modified T cell (CAR-T) manufacturing capabilities in Canada.

QMUL and BH announce major new initiative in the Life Sciences
Queen Mary University of London (QMUL) and Barts Health NHS Trust (BH) announce plans for a major new center for Life Sciences in Whitechapel, home to the Royal London Hospital and a campus of QMUL's Barts and The London School of Medicine and Dentistry.

WDS DSA announce unified requirements for Core Trustworthy Data Repositories certification
The ICSU World Data System and the Data Seal of Approval Board are pleased to announce the availability of their unified Requirements for Core Trustworthy Data Repository certification.

CDISC, C-Path, and TransCelerate announce TA standard for kidney transplant
The Coalition for Accelerating Standards and Therapies (CFAST), with TransCelerate BioPharma, Inc., announce the availability of a new Clinical Data Interchange Standards Consortium (CDISC) Therapeutic Area Standard for Kidney Transplantation -- the first CDISC standard to address a therapeutic area in the field of solid organ transplant.

AHA and China Social Assistance Foundation announce the establishment of the first AHA international training center in China with focus on bystander response to cardiac arrest
A remarkable milestone for future cooperation in the advancement of CPR training to reduce cardiovascular disease mortality.

AHA, Verily Life Sciences, AstraZeneca announce winner of $75M One Brave Idea research award
The American Heart Association (AHA), Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, and AstraZeneca, today announced that the One Brave Idea™; research award.

Read More: Announce News and Announce Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.